Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive tumor. Nivolumab showed durable antitumor effect in patients with recurrent MPM and was approved for those patients in Japan in 2018. Immune related adverse event (irAE) is occurred in various organs and is suggestive to be related...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Respir Med Case Rep
Prif Awduron: Sakakibara-Konishi, Jun, Sato, Mineyoshi, Sato, Michiko Takimoto, Kasahara, Kohei, Onozawa, Masahiro, Mizugaki, Hidenori, Kikuchi, Eiki, Asahina, Hajime, Shinagawa, Naofumi, Konno, Satoshi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2020
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378269/
https://ncbi.nlm.nih.gov/pubmed/32714828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101170
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg